par Sculier, Jean-Paul
;Lafitte, Jean-Jacques;Lecomte, J.;Alexopoulos, Constantinos;Van Cutsem, O;Giner, Vicente;Efremidis, Anna;Berchier, M.C.;Collon, Thierry;Meert, Anne-Pascale
;Scherpereel, Arnaud;Ninane, Vincent
;Paesmans, Marianne
;Berghmans, Thierry 
Référence Annals of oncology, 18, 6, page (1037-1042)
Publication Publié, 2007-06





Référence Annals of oncology, 18, 6, page (1037-1042)
Publication Publié, 2007-06
Article révisé par les pairs
Résumé : | The purpose of this study is to determine whether in advanced non-small-cell lung cancer (NSCLC), the sequential administration of cisplatin-based chemotherapy and paclitaxel (Taxol) is superior to a cisplatin-based chemotherapy, followed by paclitaxel as salvage treatment. |